Overview
Changju Ma practices practicing medicine in Guangzhou, China.
Their clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), PIK3CA-Related Overgrowth Spectrum, Lung Cancer, and Psoriasis.
They are actively involved in clinical research, co-authoring 18 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Changju Ma
Is Changju Ma a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Changju Ma is classified as an Experienced expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Changju Ma participate in research or clinical trials?
Yes. Changju Ma has published 18 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Changju Ma's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Lung CancerMa isExperienced. Learn about Lung Cancer.
- Nasopharyngeal Carcinoma
- Non-Small Cell Lung Cancer (NSCLC)
- PIK3CA-Related Overgrowth Spectrum
- PsoriasisMa isExperienced. Learn about Psoriasis.